Amprius Technologies Inc (AMPX) financial statements: income statement, balance sheet and cash flow

Amprius Technologies Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Amprius Technologies Inc reported revenue of $73.0M (+202.1% year on year) and net income of ($44.0M) (+1.4% year on year).

Income statement

Amprius Technologies Inc income statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Revenue	$73.0M	$24.2M	$9.1M	$4.4M
Cost of revenue	$64.7M	$42.5M	$23.7M	$9.8M
Gross profit (loss)	$8.3M	($18.3M)	($14.7M)	($5.4M)
Research and development	$9.4M	$7.3M	$3.7M	$2.0M
Selling, general and administrative	$23.0M	$18.7M	$20.4M	$10.6M
Impairment and other	$22.5M	—	—	—
Total operating expenses	$54.9M	$27.9M	$24.0M	$12.6M
Loss from operations	($46.6M)	($46.3M)	($38.7M)	($18.0M)
Interest income and other, net	$2.6M	$1.6M	$2.5M	$709.0K
Total other income, net	$2.6M	$1.6M	$1.9M	$709.0K
Net loss	($44.0M)	($44.7M)	($36.8M)	($17.3M)
Weighted-average common shares outstanding, basic (in shares)	124.6M	101.9M	86.2M	71.3M
Weighted-average common shares outstanding, diluted (in shares)	124.6M	101.9M	86.2M	71.3M
Net loss per share of common stock, basic (in dollars per share)	-$0.35	-$0.45	-$0.43	-$0.24
Net loss per share of common stock, diluted (in dollars per share)	-$0.35	-$0.45	-$0.43	-$0.24

Amprius Technologies Inc income statement, quarters

Line item	Jun 30, 2026 · Q2	Mar 31, 2026 · Q1	Sep 30, 2025 · Q3	Jun 30, 2025 · Q2
Revenue	$34.0M	$28.5M	$21.4M	$15.1M
Cost of revenue	$24.8M	$22.8M	$18.1M	$13.7M
Gross profit (loss)	$9.3M	$5.7M	$3.3M	$1.3M
Research and development	$4.1M	$3.8M	$2.5M	$2.2M
Selling, general and administrative	$9.5M	$8.6M	$5.5M	$6.0M
Total operating expenses	$13.6M	$12.4M	$8.0M	$8.2M
Loss from operations	($4.3M)	($6.7M)	($4.7M)	($6.8M)
Other income, net	$1.1M	$1.6M	$800.0K	$443.0K
Net loss	($3.2M)	($5.0M)	($3.9M)	($6.4M)
Increase in net loss due to warrant modification	($1.9M)	—	—	—
Net loss attributable to common stockholders	($5.1M)	—	—	—
Weighted-average common shares outstanding, basic (in shares)	143.5M	136.9M	126.6M	121.8M
Weighted-average common shares outstanding, diluted (in shares)	143.5M	136.9M	126.6M	121.8M
Net loss per share of common stock, basic (in dollars per share)	-$0.04	-$0.04	-$0.03	-$0.05
Net loss per share of common stock, diluted (in dollars per share)	-$0.04	-$0.04	-$0.03	-$0.05

Balance sheet

Amprius Technologies Inc balance sheet, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Cash and cash equivalents	$90.5M	$55.2M	$45.8M	$69.7M
Accounts receivable, net	$23.7M	$5.6M	$1.3M	$686.0K
Inventories	$6.7M	$6.6M	$730.0K	$500.0K
Prepaid expenses and other current assets	$5.5M	$1.5M	$2.0M	$2.4M
Total current assets	$126.4M	$68.8M	$50.5M	$75.2M
Property, plant and equipment, net	$9.7M	$17.5M	$21.8M	$4.2M
Operating lease right-of-use assets, net	$19.5M	$33.5M	$35.1M	$2.8M
Other assets	$1.3M	$1.4M	$305.0K	$644.0K
Total assets	$156.9M	$121.1M	$107.7M	$83.2M
Accounts payable	$6.7M	$7.4M	$3.3M	$1.0M
Accrued and other current liabilities	$3.7M	$4.8M	$5.6M	$2.7M
Deferred revenue	$100.0K	$1.6M	$3.4M	$2.7M
Deferred grant	$2.7M	—	—	—
Operating lease liabilities	$4.7M	$3.3M	$1.1M	$521.0K
Total current liabilities	$17.9M	$17.2M	$13.5M	$6.9M
Operating lease liabilities	$35.2M	$34.4M	$34.5M	$2.5M
Total liabilities	$53.1M	$51.7M	$47.9M	$10.1M
Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0	0	0
Common stock; $0.0001 par value; 950,000,000 shares authorized; 134,536,592 and 116,934,314 shares issued and outstanding at December 31, 2025 and 2024, respectively	13.0K	12.0K	9.0K	8.0K
Additional paid-in capital	$322.2M	$243.8M	$189.5M	$165.9M
Accumulated other comprehensive income	$4.0K	—	—	—
Accumulated deficit	($218.4M)	($174.3M)	($129.7M)	($92.9M)
Total stockholders’ equity	$103.8M	$69.5M	$59.8M	$73.0M
Total liabilities and stockholders’ equity	$156.9M	$121.1M	$107.7M	$83.2M

Amprius Technologies Inc balance sheet, quarters

Line item	Jun 30, 2026	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025
Cash and cash equivalents	$74.5M	$62.4M	$73.2M	$54.2M
Accounts receivable, net	$40.6M	$35.3M	$21.9M	$10.8M
Inventories	$11.5M	$8.2M	$4.7M	$4.3M
Prepaid expenses and other current assets	$4.9M	$8.1M	$6.9M	$2.6M
Total current assets	$131.6M	$114.0M	$106.7M	$71.9M
Property, plant and equipment, net	$11.7M	$10.7M	$16.3M	$17.3M
Operating lease right-of-use assets, net	$5.8M	$6.0M	$32.2M	$32.6M
Other assets	$63.0K	$62.0K	$1.3M	$1.3M
Total assets	$149.2M	$130.8M	$156.5M	$123.0M
Accounts payable	$9.8M	$8.9M	$7.8M	$3.7M
Accrued and other current liabilities	$4.3M	$3.2M	$4.3M	$4.1M
Deferred grant	$2.7M	$2.7M	$2.7M	—
Deferred revenue	$413.0K	$18.0K	$705.0K	$840.0K
Operating lease liabilities	$1.2M	$1.2M	$3.2M	$3.4M
Total current liabilities	$18.4M	$16.0M	$16.1M	$12.1M
Operating lease liabilities	$5.2M	$5.4M	$34.5M	$34.3M
Total liabilities	$23.5M	$21.4M	$53.3M	$46.4M
Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0	0	0
Common stock; $0.0001 par value; 950,000,000 shares authorized; 146,080,618 and 134,536,592 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	14.0K	13.0K	13.0K	13.0K
Additional paid-in capital	$352.2M	$332.8M	$297.1M	$266.7M
Accumulated other comprehensive income	$23.0K	$10.0K	($3.0K)	($7.0K)
Accumulated deficit	($226.6M)	($223.4M)	($194.0M)	($190.1M)
Total stockholders’ equity	$125.6M	$109.4M	$103.2M	$76.7M
Total liabilities and stockholders’ equity	$149.2M	$130.8M	$156.5M	$123.0M

Cash flow statement

Amprius Technologies Inc cash flow statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Net loss	($44.0M)	($44.7M)	($36.8M)	($17.3M)
Stock-based compensation	$7.4M	$7.3M	$3.9M	$2.7M
Depreciation and amortization	$4.4M	$3.8M	$1.8M	$1.5M
Amortization of deferred costs	$0	$1.2M	$3.1M	$1.6M
Non-cash operating lease expense	$5.1M	$5.1M	$1.1M	$556.0K
Impairment and other	$22.5M	—	—	—
Other non-cash items	$454.0K	—	—	—
Accounts receivable, net	($18.6M)	($4.3M)	($579.0K)	($424.0K)
Inventories	($161.0K)	($5.8M)	($230.0K)	$0
Deferred costs	$0	($467.0K)	($1.6M)	($1.9M)
Prepaid expenses and other current assets	($3.8M)	$533.0K	$407.0K	($2.3M)
Other assets	$28.0K	($17.0K)	($9.0K)	—
Accounts payable	($998.0K)	$5.9M	$616.0K	$517.0K
Accrued and other current liabilities	($1.2M)	($747.0K)	$3.1M	$1.2M
Deferred revenue	($1.5M)	($1.8M)	$54.0K	$516.0K
Deferred grant	$2.7M	—	—	—
Operating lease liabilities	($3.5M)	($1.3M)	($1.0M)	($482.0K)
Net cash used in operating activities	($31.1M)	($33.4M)	($25.6M)	($13.9M)
Purchase of property, plant and equipment	($4.4M)	($3.2M)	($17.6M)	($1.5M)
Net cash used in investing activities	($4.4M)	($3.2M)	($17.6M)	($1.5M)
Proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement, net	$63.7M	$33.4M	$19.5M	$77.9M
Proceeds from issuance of common stock upon exercise of stock warrants	$2.3M	$14.4M	$1.0K	$2.5M
Payment of equity financing costs	$0	($756.0K)	($601.0K)	($326.0K)
Proceeds from exercise of stock options	$5.1M	$109.0K	$310.0K	$44.0K
Net cash provided by financing activities	$71.0M	$47.2M	$19.2M	$73.6M
Net increase in cash, cash equivalents and restricted cash equivalents	$35.5M	—	—	—
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents	$4.0K	—	—	—
Cash, cash equivalents and restricted cash equivalents, beginning of year	$56.4M	$45.8M	$69.8M	$11.5M
Cash, cash equivalents and restricted cash equivalents, end of year	$91.9M	$56.4M	—	—
Cash and cash equivalents	$90.5M	$55.2M	$45.8M	$69.7M
Restricted cash equivalents included in prepaid expenses and other current assets	$200.0K	—	—	—
Restricted cash equivalents included in other assets	$1.3M	$1.3M	—	—
Total cash, cash equivalents and restricted cash equivalents	$91.9M	$56.4M	—	—
Unpaid purchases of property, plant and equipment	$322.0K	$48.0K	$1.9M	$83.0K
Increase in fair value of modified stock warrants	$0	$727.0K	—	—
Cancellation and retirement of common stock	$0	$1.0K	—	—

Amprius Technologies Inc cash flow statement, quarters

Line item	Jun 30, 2026 · YTD	Mar 31, 2026 · Q1	Sep 30, 2025 · YTD	Jun 30, 2025 · YTD
Net loss	($8.2M)	($5.0M)	($19.6M)	($15.7M)
Stock-based compensation	$4.6M	$2.1M	$5.5M	$3.7M
Depreciation and amortization	$1.5M	$761.0K	$3.1M	$2.0M
Loss on termination of lease	$166.0K	$166.0K	—	—
Write-down of property, plant and equipment	$77.0K	$77.0K	—	—
Non-cash operating lease expense	$928.0K	$619.0K	$3.9M	$2.6M
Gain on disposal of property, plant and equipment	($355.0K)	($355.0K)	—	—
Other non-cash items	($22.0K)	($22.0K)	$444.0K	$818.0K
Accounts receivable, net	($16.8M)	($11.5M)	($16.8M)	($6.0M)
Inventories	($4.8M)	($1.5M)	$1.9M	$2.2M
Prepaid expenses and other current assets	$594.0K	($2.6M)	($2.5M)	($911.0K)
Other assets	($11.0K)	$13.0K	$26.0K	$20.0K
Accounts payable	$2.5M	$1.6M	$467.0K	($3.8M)
Accrued and other current liabilities	$288.0K	($898.0K)	($538.0K)	($758.0K)
Deferred revenue	$312.0K	($82.0K)	($933.0K)	($798.0K)
Operating lease liabilities	($20.9M)	($20.6M)	($2.6M)	($1.7M)
Net cash used in operating activities	($40.1M)	($37.3M)	($27.6M)	($18.4M)
Purchase of property, plant and equipment	($2.8M)	($980.0K)	($2.0M)	($1.6M)
Proceeds from the disposal of property, plant and equipment	$355.0K	$355.0K	—	—
Net cash used in investing activities	($2.4M)	($625.0K)	($2.0M)	($1.6M)
Proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement, net	$0	$0	$44.1M	$18.2M
Proceeds from exercise of warrants	$14.2M	$1.9M	$0	$0
Proceeds from exercise of stock options	$11.2M	$6.7M	$3.9M	$1.1M
Net cash provided by financing activities	$25.4M	$8.6M	$48.0M	$19.3M
Net decrease in cash, cash equivalents and restricted cash equivalents	($17.2M)	($29.3M)	$18.3M	($759.0K)
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents	$19.0K	$6.0K	($3.0K)	($7.0K)
Cash, cash equivalents and restricted cash equivalents, beginning of period	$91.9M	$91.9M	$56.4M	$56.4M
Cash, cash equivalents and restricted cash equivalents, end of period	$74.8M	$62.6M	$74.7M	$55.6M
Cash and cash equivalents	$74.5M	$62.4M	$73.2M	$54.2M
Restricted cash equivalents included in prepaid expenses and other current assets	$200.0K	$200.0K	$200.0K	$200.0K
Restricted cash equivalents included in other assets	$56.0K	$56.0K	$1.3M	$1.3M
Total cash, cash equivalents and restricted cash equivalents	$74.8M	$62.6M	$74.7M	$55.6M
Unpaid purchases of property, plant and equipment	$1.1M	$1.2M	—	—
Right-of-use asset and operating lease obligations from new lease	$105.0K	$105.0K	—	—
Right-of-use assets derecognized in connection with lease termination	$13.4M	$13.4M	—	—

Amprius Technologies Inc score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.